Pr Laurent Greillier, Oncologist, lung expert

Specialty

Oncologist, lung expert

Title

Head of department

Hospital

AP-HM Hôpital Nord (Marseille)

Latest articles

First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations. (May 29, 2026)
Phase II study of magrolimab combined with docetaxel in previously treated metastatic advanced solid tumors. (Apr 22, 2026)
Association of Sleep-Related Hypoxemia With Survival in Patients With Non-Small Cell Lung Cancer: The NEOSAS Groupe Français de Pneumo-Cancérologie Study Group. (Mar 9, 2026)
Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer. (Mar 1, 2026)
Durvalumab in Patients With Treatment-Naive Stage IV NSCLC With an ECOG Performance Status of 2 to 3 and High PD-L1 Tumor Expression (IFCT-1802 SAVIMMUNE): A Multicenter Phase 2 Trial. (Sep 18, 2025)